Triazolam Tablet
Product Images NDC 70771-1162

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triazolam (NDC 70771-1162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.125 mg Label (D38f9207 Dcd6 46ef B9e9 9d02463ef1ba 01)

0.125 mg  Label (D38f9207 Dcd6 46ef B9e9 9d02463ef1ba 01)
Triazolam Tablets USP 0.125 mg oral tablets in a pack of 10, labeled for prescription use only. The label includes storage instructions, pharmacist dispensing guidance, and manufacturer information for Cadila Healthcare Ltd., Ahmedabad, India. The labeler is Zydus Lifesciences Limited.*
FDA Label Image

0.25 mg Label (D38f9207 Dcd6 46ef B9e9 9d02463ef1ba 02)

0.25 mg Label (D38f9207 Dcd6 46ef B9e9 9d02463ef1ba 02)
Triazolam Tablets USP 0.25 mg oral tablets label. The package contains 10 tablets, labeled as Rx only. The label includes instructions for pharmacists to dispense the Medication Guide and storage conditions. The product is manufactured by Cadila Healthcare Ltd, Ahmedabad, India, and labeled by Zydus Lifesciences Limited. The NDC is 70771-1162-8.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.